Literature DB >> 18413238

Rab8-optineurin-myosin VI: analysis of interactions and functions in the secretory pathway.

Margarita V Chibalina1, Rhys C Roberts, Susan D Arden, John Kendrick-Jones, Folma Buss.   

Abstract

The small GTPase Rab8 has been shown to regulate polarized membrane trafficking pathways from the TGN to the cell surface. Optineurin is an effector protein of Rab8 and a binding partner of the actin-based motor protein myosin VI. We used various approaches to study the interactions between myosin VI and its binding partners and to analyze their role(s) in intracellular membrane trafficking pathways. In this chapter, we describe the use of the mammalian two-hybrid assay to demonstrate protein-protein interactions and to identify binding sites. We describe a secretion assay that was used in combination with RNA interference technology to analyze the function of myosin VI, optineurin, and Rab8 in exocytic membrane trafficking pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413238      PMCID: PMC2619538          DOI: 10.1016/S0076-6879(07)38002-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  30 in total

1.  COP I domains required for coatomer integrity, and novel interactions with ARF and ARF-GAP.

Authors:  A Eugster; G Frigerio; M Dale; R Duden
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

2.  The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest.

Authors:  C T Chien; P L Bartel; R Sternglanz; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells.

Authors:  J Berger; J Hauber; R Hauber; R Geiger; B R Cullen
Journal:  Gene       Date:  1988-06-15       Impact factor: 3.688

4.  Myosin VI targeting to clathrin-coated structures and dimerization is mediated by binding to Disabled-2 and PtdIns(4,5)P2.

Authors:  Giulietta Spudich; Margarita V Chibalina; Josephine Sui-Yan Au; Susan D Arden; Folma Buss; John Kendrick-Jones
Journal:  Nat Cell Biol       Date:  2006-12-24       Impact factor: 28.824

5.  Loss of myosin VI reduces secretion and the size of the Golgi in fibroblasts from Snell's waltzer mice.

Authors:  Claire L Warner; Abigail Stewart; J Paul Luzio; Karen P Steel; Richard T Libby; John Kendrick-Jones; Folma Buss
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

6.  Novel association of hypertrophic cardiomyopathy, sensorineural deafness, and a mutation in unconventional myosin VI (MYO6).

Authors:  S A Mohiddin; Z M Ahmed; A J Griffith; D Tripodi; T B Friedman; L Fananapazir; R J Morell
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

7.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons.

Authors:  M DiFiglia; E Sapp; K Chase; C Schwarz; A Meloni; C Young; E Martin; J P Vonsattel; R Carraway; S A Reeves
Journal:  Neuron       Date:  1995-05       Impact factor: 17.173

8.  Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis.

Authors:  Daniela A Sahlender; Rhys C Roberts; Susan D Arden; Giulietta Spudich; Marcus J Taylor; J Paul Luzio; John Kendrick-Jones; Folma Buss
Journal:  J Cell Biol       Date:  2005-04-18       Impact factor: 10.539

9.  Rab8, a small GTPase involved in vesicular traffic between the TGN and the basolateral plasma membrane.

Authors:  L A Huber; S Pimplikar; R G Parton; H Virta; M Zerial; K Simons
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

10.  Protein transport to the dendritic plasma membrane of cultured neurons is regulated by rab8p.

Authors:  L A Huber; M J de Hoop; P Dupree; M Zerial; K Simons; C Dotti
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

View more
  22 in total

Review 1.  Cellular and molecular biology of optineurin.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Inducible turnover of optineurin regulates T cell activation.

Authors:  Angela Montecalvo; Simon C Watkins; Jordan Orange; Lawrence P Kane
Journal:  Mol Immunol       Date:  2017-02-11       Impact factor: 4.407

3.  From the Cover: Alterations in Optineurin Expression and Localization in Pre-clinical Parkinson's Disease Models.

Authors:  John Pierce Wise; Jason Cannon
Journal:  Toxicol Sci       Date:  2016-07-29       Impact factor: 4.849

Review 4.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

5.  Posttranslational modifications, localization, and protein interactions of optineurin, the product of a glaucoma gene.

Authors:  Hongyu Ying; Xiang Shen; BumChan Park; Beatrice Y J T Yue
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

6.  Impairment of protein trafficking upon overexpression and mutation of optineurin.

Authors:  BumChan Park; Hongyu Ying; Xiang Shen; Jeong-Seok Park; Ye Qiu; Rajalekshmy Shyam; Beatrice Y J T Yue
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

Review 7.  Molecular complexity of primary open angle glaucoma: current concepts.

Authors:  Kunal Ray; Suddhasil Mookherjee
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

8.  Myocilin and Optineurin: Differential Characteristics and Functional Consequences.

Authors:  Beatrice Y J T Yue
Journal:  Taiwan J Ophthalmol       Date:  2011-11-01

9.  Engaging myosin VI tunes motility, morphology and identity in endocytosis.

Authors:  Michael Ritt; Sivaraj Sivaramakrishnan
Journal:  Traffic       Date:  2018-06-04       Impact factor: 6.215

10.  Guanine nucleotide exchange factors activate Rab8a for Toll-like receptor signalling.

Authors:  Samuel J Tong; Adam A Wall; Yu Hung; Lin Luo; Jennifer L Stow
Journal:  Small GTPases       Date:  2019-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.